Pages that link to "Q31101983"
Jump to navigation
Jump to search
The following pages link to Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort (Q31101983):
Displaying 34 items.
- Albumin-based drug delivery: harnessing nature to cure disease (Q26765789) (← links)
- Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis (Q26784192) (← links)
- Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials (Q26800254) (← links)
- Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics (Q34620581) (← links)
- Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes (Q34726409) (← links)
- Detemir as a once-daily basal insulin in type 2 diabetes (Q35683978) (← links)
- 3-Month Results from Denmark within the Globally Prospective and Observational Study to Evaluate Insulin Detemir Treatment in Type 1 and Type 2 Diabetes: The PREDICTIVE Study (Q36084624) (← links)
- Treatment of type 1 and type 2 diabetes mellitus with insulin detemir, a long-acting insulin analog (Q36139042) (← links)
- Efficacy and safety of insulin degludec in Japanese patients with type 1 and type 2 diabetes: 24-week results from the observational study in routine clinical practice. (Q36477634) (← links)
- Intensive diabetes therapy and body weight: focus on insulin detemir (Q36946307) (← links)
- Comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes: assessment of detemir administration in a progressive treat-to-target trial (ADAPT). (Q37022851) (← links)
- Diabetes care - insulin delivery in a changing world (Q37205834) (← links)
- New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations (Q37242616) (← links)
- Deleterious outcomes after abrupt transition from insulin glargine to insulin detemir in patients with type 1 diabetes mellitus (Q37288770) (← links)
- Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes (Q37405567) (← links)
- Insulin Detemir in Combination with Oral Antidiabetic Drugs Improves Glycemic Control in Persons with Type 2 Diabetes in Near East Countries: Results from the Lebanese Subgroup (Q37863353) (← links)
- Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus (Q37737461) (← links)
- Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs (Q37893971) (← links)
- Cost–effectiveness of insulin detemir: a systematic review (Q37941075) (← links)
- Insulin analogues: how observational studies provide key insights into management of patients with type 2 diabetes mellitus (Q37951999) (← links)
- Insulin detemir: a review of its use in the management of diabetes mellitus (Q38056540) (← links)
- A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial. (Q38373738) (← links)
- Insulin analogues in type 1 diabetes mellitus: getting better all the time (Q38692387) (← links)
- Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes (Q38824504) (← links)
- Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects. (Q42619686) (← links)
- The A1chieve study: a 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice (Q42660530) (← links)
- An increased dose of insulin detemir improves glycaemic control and reduces body weight of Japanese patients with diabetes (Q42949450) (← links)
- Insulin detemir in routine clinical practice: a 26-week follow-up in type 1 diabetic patients from the Belgian PREDICTIVE Cohort (Q46076995) (← links)
- The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study (Q46986307) (← links)
- Floxuridine Homomeric Oligonucleotides "Hitchhike" with Albumin In Situ for Cancer Chemotherapy (Q57093350) (← links)
- The Incidence of Hypoglycemia among Insulin-Treated Patients with Type 1 or Type 2 Diabetes: Bangladeshi Cohort of International Operations-Hypoglycemia Assessment Tool Study (Q57928302) (← links)
- Effectiveness and safety of insulin glargine detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis (Q58817760) (← links)
- Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study (Q89484275) (← links)
- Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies (Q93233974) (← links)